Docoh
Loading...

Tue. 4 May 2021, 6:23am ETBenzinga
In: News, Price Target, Initiation, Analyst Ratings
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Reneo Pharmaceuticals (NASDAQ:RPHM) with a Overweight rating and announces Price Target of $45.